NextGen Healthcare, Inc.
NXGN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,155 | $1,409 | $1,208 | $684 |
| - Cash | $99 | $60 | $73 | $138 |
| + Debt | $275 | $20 | $31 | $178 |
| Enterprise Value | $1,331 | $1,369 | $1,166 | $724 |
| Revenue | $653 | $596 | $557 | $540 |
| % Growth | 9.5% | 7.1% | 3.1% | – |
| Gross Profit | $311 | $301 | $281 | $273 |
| % Margin | 47.6% | 50.5% | 50.5% | 50.5% |
| EBITDA | $48 | $53 | $70 | $25 |
| % Margin | 7.4% | 9% | 12.6% | 4.7% |
| Net Income | -$3 | $2 | $10 | $7 |
| % Margin | -0.4% | 0.3% | 1.7% | 1.4% |
| EPS Diluted | -0.04 | 0.02 | 0.14 | 0.11 |
| % Growth | -298% | -85.7% | 27.3% | – |
| Operating Cash Flow | $44 | $54 | $99 | $86 |
| Capital Expenditures | -$37 | -$28 | -$28 | -$27 |
| Free Cash Flow | $6 | $25 | $70 | $59 |